This cohort study involves the dynamic collection of clinical information, including serum parameters , blood pressure variability, imaging data, and neuropsychological scales, in patients with cerebral small vessel disease (CSVD). The study aims to summarise the clinical and imaging characteristics of the CSVD population and identify novel CSVD risk factors. Additionally, this study intend to uncover the mechanisms underlying the clinical and imaging outcomes of CSVD. Furthermore, a multivariable prediction model for cognitive and mood disorders in patients with CSVD will be established.
Research Objectives: 1. To conduct a longitudinal study on patients with cerebral small vessel disease (CSVD) and observe the dynamic evolution of their cognitive functioning, emotional disorders, and other related factors. 2. To explore and summarize the clinical and radiological characteristics of the CSVD population, and identify new risk factors for CSVD. 3. To investigate in depth the underlying mechanisms and the relationship between clinical and radiological outcomes in CSVD. 4. To establish a multifactor prediction model for cognitive and emotional disorders in CSVD.
Study Type
OBSERVATIONAL
Enrollment
1,078
Main measures and data collection methods: 1. Recording of baseline demographic and clinical information of the participants. 2. Multimodal magnetic resonance imaging 3. blood pressure variability. 4. neuropsychological testing 5. Blood samples collection
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Shanghai, China
RECRUITINGCognitive state
The cognitive function assessment based on Montreal Cognitive Assessment(MoCA) scale.
Time frame: 2020-12-1 to 2027-12-31
Blood pressure variability
24-hour ambulatory blood pressure
Time frame: 2020-12-1 to 2027-12-31
The development of white matter hyperintensities, microbleeds, lacunes and, perivascular spaces.
If the fine structures are not clearly visible on the 3.0T MRI and further evaluation is needed for the clinical and therapeutic assessment of cerebral small vessel disease, the patient will be referred to undergo a 7.0T MRI examination.
Time frame: 2020-12-1 to 2027-12-31
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.